Finance

Beta
Lists
SYRS:OTCMKTS
Syros Pharmaceuticals Inc
$0.00040
+100.00%
(+0.00020) 1D
Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SYRS...
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
10.73K
Avg. vol.
9.94K
Volume
445.00
52-wk high
$0.04
52-wk low
$0.00
Beta
0.83
Shares outstanding
26.83M
No. of employees
68
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
10.73K
Avg. vol.
9.94K
Volume
445.00
52-wk high
$0.04
52-wk low
$0.00
Beta
0.83
Shares outstanding
26.83M
No. of employees
68
News stories
From sources across the web
About Syros Pharmaceuticals Inc
CEO-
Employees68
Founded2011
Headquarters-
SectorBiotechnology
Websitesyros.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Revenue
386.00K
-
-
-
Cost of goods sold
-
24.66M
21.95M
20.53M
Cost of revenue
-
24.66M
21.95M
20.53M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
6.27M
5.46M
5.66M
Operating expense
-
6.27M
5.46M
5.66M
Total operating expenses
-
30.92M
27.42M
26.18M
Operating income
-
-30.92M
-27.42M
-26.18M
Other non operating income
-
26.97M
4.39M
20.30M
EBT including unusual items
-
-3.71M
-23.33M
-6.40M
EBT excluding unusual items
-
-3.71M
-23.33M
-6.40M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-
-3.71M
-23.33M
-6.40M
Net profit margin
-
-
-
-
Earnings per share
-2.22
-0.10
-0.59
-0.16
Interest and investment income
-
1.55M
1.08M
793.00K
Interest expense
-
-1.31M
-1.38M
-1.31M
Net interest expenses
-
239.00K
-297.00K
-519.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-30.59M
-27.08M
-25.86M
Gain or loss from assets sale
-
-29.00K
-96.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer